1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB

Genmab - ADR Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

Read More
28.84 -0.35 (-1.20%)
67.29% Gain from 52W Low
3.8M
XNAS Volume

XNAS 06 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Genmab - ADR took place on 06 Nov 2025, for the purpose of Genmab AS Third Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
45.8 / 100
Momentum Score
Technically Neutral
55.8 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
38
1Yr Price target upside is 30%
7 analysts

13

S

6

W

6

O

0

T

SWOT Analysis

Genmab ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..